ScholarIQanswers from OpenAlex
Salford Royal NHS Foundation Trust
InstitutionResearch output, impact & collaborations
Salford Royal NHS Foundation Trust is a institution indexed in ScholarIQ from OpenAlex.
What is known about Salford Royal NHS Foundation Trust?
ScholarIQrecord summary
Salford Royal NHS Foundation Trust is a research organisation in Salford, GB. OpenAlex records 7,677 works and 608,218 citations for it. 1,578 researchers list it as their most recent affiliation.
How many works does Salford Royal NHS Foundation Trust have?
ScholarIQindexed works
Salford Royal NHS Foundation Trust has 7,677 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Salford Royal NHS Foundation Trust have?
ScholarIQcitation count
Salford Royal NHS Foundation Trust has 608,218 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Salford Royal NHS Foundation Trust?
ScholarIQresearcher count
Salford Royal NHS Foundation Trust has 1,578 researchers in the ScholarIQ index.
What is the average h-index at Salford Royal NHS Foundation Trust?
ScholarIQavg h-index
Salford Royal NHS Foundation Trust has an average h-index of 51.8 in OpenAlex.
What is the ROR of Salford Royal NHS Foundation Trust?
ScholarIQror
The ROR for Salford Royal NHS Foundation Trust is on the source record.
What is the OpenAlex record for Salford Royal NHS Foundation Trust?
ScholarIQopenalex
The OpenAlex for Salford Royal NHS Foundation Trust is on the source record.
Who are the most-cited researchers behind Salford Royal NHS Foundation Trust?
ScholarIQtop researchers by citations
What are the most-cited papers on Salford Royal NHS Foundation Trust?
ScholarIQmost cited works
Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial
Nicholas D. James, Matthew R. Sydes, Noel W. Clarke, Malcolm D. Mason, David P. Dearnaley, Melissa Spears, A.W.S. Ritchie, Christopher Parker, John M. Russell, Gerhardt Attard, Johann S. de Bono, William Cross, Robert J. Jones, George N. Thalmann, Claire Amos, David Matheson, Robin Millman, Mymoona Alzouebi, S. Beesley, Alison Birtle, Susannah Brock, Richard Cathomas, Prabir Chakraborti, Simon Chowdhury, Audrey Cook, Tony Elliott, Joanna Gale, Stephanie Gibbs, John D. Graham, John Hetherington, Robert Hughes, Robert Laing, Fiona McKinna, Duncan B. McLaren, Joe M. O’Sullivan, Omi Parikh, C. Peedell, Andrew Protheroe, Angus Robinson, Narayanan Srihari, Rajaguru Srinivasan, John Staffurth, Santhanam Sundar, Shaun Tolan, David Tsang, John Wagstaff, Mahesh Parmar
Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy
Nicholas D. James, Johann S. de Bono, Melissa Spears, Noel W. Clarke, Malcolm D. Mason, David P. Dearnaley, A.W.S. Ritchie, Claire Amos, Clare Gilson, Robert J. Jones, David Matheson, Robin Millman, Gerhardt Attard, Simon Chowdhury, William Cross, Silke Gillessen, Christopher Parker, John M. Russell, Dominik Berthold, Chris Brawley, F. Adab, San Aung, Alison Birtle, Jo Bowen, Susannah Brock, Prabir Chakraborti, Catherine Ferguson, Joanna Gale, Emma Gray, Mohan Hingorani, Peter Hoskin, J.F. Lester, Zafar Malik, Fiona McKinna, Neil McPhail, Julian Money‐Kyrle, Joe M. O’Sullivan, Omi Parikh, Andrew Protheroe, Angus Robinson, Narayanan Srihari, Carys Thomas, John Wagstaff, James Wylie, Anjali Zarkar, Mahesh Parmar, Matthew R. Sydes
Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial
Christopher Parker, Nicholas D. James, Chris Brawley, Noel W. Clarke, Alex Hoyle, Adnan Ali, A.W.S. Ritchie, Gerhardt Attard, Simon Chowdhury, William Cross, David P. Dearnaley, Silke Gillessen, Clare Gilson, Robert J. Jones, Ruth E. Langley, Zafar Malik, Malcolm D. Mason, David Matheson, Robin Millman, John M. Russell, George N. Thalmann, Claire Amos, Roberto Alonzi, Amit Bahl, Alison Birtle, Omar Din, Hassan Douis, Chinnamani Eswar, Joanna Gale, Melissa Gannon, Sai Jonnada, Sara Khaksar, J.F. Lester, Joe M. O’Sullivan, Omi Parikh, Ian Pedley, Delia Pudney, D.J. Sheehan, Narayanan Srihari, Anna Tran, Mahesh Parmar, Matthew R. Sydes
ESPEN guidelines on chronic intestinal failure in adults
Loris Pironi, Jann Arends, Federico Bozzetti, Cristina Cuerda, Lyn Gillanders, Palle Bekker Jeppesen, Francisca Joly, Darlene G. Kelly, Simon Lal, Michael Staun, Kinga Szczepanek, A. Van Gossum, Geert Wanten, S. Schneider
Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017
Silke Gillessen, Gerhardt Attard, Tomasz M. Beer, Himisha Beltran, Alberto Bossi, Robert G. Bristow, Brett S. Carver, Daniel Castellano, Byung Ha Chung, Noel W. Clarke, Gedske Daugaard, Ian D. Davis, Johann S. de Bono, Rodolfo Borges dos Reis, Charles G. Drake, Rosalind A. Eeles, Eleni Efstathiou, Christopher P. Evans, Stefano Fanti, Felix Y. Feng, Karim Fizazi, Mark Frydenberg, Martin Gleave, Susan Halabi, Axel Heidenreich, Celestia S. Higano, Nicolas James, Philip W. Kantoff, Pirkko‐Liisa Kellokumpu‐Lehtinen, Raja B. Khauli, Gero Kramer, Chris Logothetis, Fernando Cotait Maluf, Alicia K. Morgans, Michael J. Morris, Nicolas Mottet, Vedang Murthy, William Oh, Piet Ost, Anwar R. Padhani, Chris Parker, Colin C. Pritchard, Mack Roach, Mark A. Rubin, Charles J. Ryan, Fred Saad, Oliver Sartor, Howard I. Scher, Avishay Sella, Neal D. Shore, Matthew R. Smith, Howard R. Soule, Cora N. Sternberg, Hiroyoshi Suzuki, Christopher J. Sweeney, Matthew R. Sydes, Ian F. Tannock, Bertrand Tombal, R. Valdagni, Thomas Wiegel, Aurelius Omlin
How much of the research on Salford Royal NHS Foundation Trust is open access?
ScholarIQopen access share
75%OPEN ACCESS